U.S. Market for Chronic Venous Insufficiency Treatment 2009

Publication Date	March 2009
Publisher	iData Research
Product Type	Report
Pages	53
ISBN Number	not applicable
Product Code	IDR00103

Buy this product or for assistance call +44 20 7060 7474

PDF £4,505.00$7494 | €5042

PRINT £4,205.00$6995 | €4706

FAX Order above formats by FAX

Summary

CVI is the underlying cause for a majority of lower leg venous ulcers. Compression treatment with Unna boots is the most widely used treatment for venous ulcers, with over 50% of patients using them. Both the number of patients with CVI and the number of patients diagnosed is expected to increase over the forecast period, due to the aging population, increasing obesity, and growing awareness of CVI among medical professionals.

Content

Executive Summary
- 1.1 Patient Population for Chronic Venous Insufficiency
- 1.2 Unna Boot Market
- 1.3 Unna Boot Competitive Analysis
Research Methodology
- 2.1 Research Scope
- 2.2 Idata's 9-Step Methodology
- 2.2.1 Step 1: Project Initiation & Team Selection
- 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
- 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
- 2.2.4 Step 4: Performing Primary Research
- 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
- 2.2.6 Step 6: Market Forecast and Analysis
- 2.2.7 Step 7: Identify Strategic Opportunities
- 2.2.8 Step 8: Final Review and Market Release
- 2.2.9 Step 9: Customer Feedback and Market Monitoring
Chronic Venous Insufficeincy Market
- 3.1 Introduction
- 3.2 Chronic Venous Insufficiency Overview
- 3.2.1 Potential Patient Population
- 3.3 Cvi Patients with Chronic Venous Ulcers
- 3.4 Chronic Venous Ulcer Treatment Breakdown
- 3.5 Costs of Cvi and Venous Ulcers
- 3.6 Chronic Venous Insufficiency Potential Market
- 3.7 Market Drivers and Limiters
- 3.7.1 Market Drivers
- 3.7.2 Market Limiters
Unna Boot Market
- 4.1 Introduction
- 4.2 Market Analysis and Forecast
- 4.2.1 Unna Boot Applications
- 4.2.2 Unna Boot Market
- 4.2.3 Unna Boots Segmented by Width
- 4.2.4 Unna Boot Price Segmentation
- 4.3 Market Drivers and Limiters
- 4.3.1 Market Drivers
- 4.3.2 Market Limiters
- 4.4 Competitive Analysis
Abbreviations
List of Figures
- Executive Summary
- Research Methodology
- Chronic Venous Insufficeincy Market
  - Figure 3-1: Chronic Venous Insufficiency Patient Population, U.S., 2005 - 2015
  - Figure 3-2: Chronic Ulcer Treatment Breakdown, U.S., 2005 - 2015
  - Figure 3-3: Surgical Cvi Treatment Potential Population, U.S., 2005 - 2015
  - Figure 3-4: Drivers and Limiters for The Cvi Treatment Market, U.S., 2008
- Unna Boot Market
  - Figure 4-1: Unna Boot Applications, U.S, 2005 - 2015
  - Figure 4-2: Unna Boot Market, U.S., 2005 - 2015
  - Figure 4-3: Unna Boot Units Sold by Width, U.S., 2005 - 2015
  - Figure 4-4: Unna Boot Price Segmentation, U.S., 2008
  - Figure 4-5: Drivers and Limiters for The Unna Boot Market, U.S., 2008
  - Figure 4-6: Leading Competitors in The Compression Bandage Market, U.S., 200838
- Abbreviations
List of Charts
- Executive Summary
  - Chart 1-1: Cvi and Venous Ulcer Patient Populations, U.S. 2005 - 2015
  - Chart 1-2: Unna Boot Market, U.S., 2005 - 2015
  - Chart 1-3: Leading Competitors in The Unna Boot Market, U.S., 2008
- Research Methodology
  - Chronic Venous Insufficeincy Market
  - Chart 3-1: Cost Breakdown for Venous Ulcer Treatment, U.S. 2008
- Unna Boot Market
  - Chart 4-1: Unna Boot Market, U.S., 2005 - 2015
  - Chart 4-2: Unna Boot Units Sold by Width, U.S., 2005 - 2015
  - Chart 4-3: Unna Boot Price Segmentation, U.S., 2008
  - Chart 4-4: Leading Competitors in The Unna Boot Market, U.S., 2008
- Abbreviations